Trials / Completed
CompletedNCT02063477
Effect of Oligopin® on Blood Pressure.
Effect of a French Maritim Pine Bark Extract Oligopin® on Blood Pressure: Double Blind, Crossover, Placebo-controlled Nutrition Intervention Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Technological Centre of Nutrition and Health, Spain · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to evaluate the effect of consumption of a food supplement rich in procyanidins extracted from the bark of French pine, Oligopin®, on blood pressure of people with mild / moderate degree of hypertension. Furthermore, the effect Oligopin® consumption on markers involved in the development of hypertension, and endothelial function in key enzymes that regulate blood pressure, inflammation and oxidation are considered. Also, try to advance the understanding of the molecular mechanisms that regulate blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | The placebo composition is for 1 gelule: 250 mg maltodextrin + 30 mg magnesium stearate; total weight: 280 mg/gelule |
| DIETARY_SUPPLEMENT | Oligopin® | Oligopin® PUR' expert (%) is a red brown powder extracted from the bark of the Maritime Pine (Pinus pinaster) with composition: \- TOTAL POLYPHENOL CONTENT \> 96 1. MONOMERS + PHENOLIC ACIDS 30 2. DIMERS \>15 3. OTHER OLIGOMERS 50 PROCYANIDINS CONTENT (GPC) \> 67 The Oligopin composition is for 1 gelule: 75 mg Oligopin + 175 mg maltodextrine + 30 mg magnesium stearate: total weight: 280 mg/gelule |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-09-01
- Completion
- 2014-10-01
- First posted
- 2014-02-14
- Last updated
- 2022-02-28
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02063477. Inclusion in this directory is not an endorsement.